67 results
Page 2 of 4
S-4/A
bww 028ycscp4hhm
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
CORRESP
lsyn0vdtmw0jm7v3guh
25 Aug 23
Correspondence with SEC
12:00am
UPLOAD
slbbhrvote1 dpclwnub
16 Aug 23
Letter from SEC
12:00am
S-4
EX-3.3
snmxg0xnze43w kxdp5
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
EX-10.4
ulvprb
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
25oz5pc070a76l4znup
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
EX-10.15
x83w0dj3lom3
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
2ge76kre
22 Jun 23
Business combination disclosure
9:12am
8-K
EX-2.1
7umvgm8ox47vei6v
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
8-K
EX-99.1
g6eoa7h3w 8ct
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
8-K
EX-99.2
5v8 3f4vlp6i8okzio
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
8-K
EX-99.1
hu2874ayv fk06zh
10 Nov 22
Talaris Therapeutics Announces Third Quarter Financial Results and Corporate Update
7:12am
8-K
EX-99.1
gsabcl
20 Oct 22
Talaris Therapeutics Provides Update on FREEDOM-1 Phase 3 Clinical Trial
7:12am
S-3
m02zbwjws678jt8g11k9
15 Aug 22
Shelf registration
5:06pm